Eli Lilly and Company LLY
1,409.38 USD -1.61 (-0.11%)
At closeNov 3, 2026, 4:57 PM EST
1,407.00 -2.38 -0.17%
After hours · Nov 3, 4:57 PM ET
1,393.61 Day range 1,437.00
850.51 52-week range 1,449.68
- YTD
- +31.14%
- 1 year
- +57.20%
Analyst view
Consensus: buy
Buy
Price target (mean) 1,442.09 +2.3% upside
Now 1,409.38
- Target (low)
- 930.00
- Target (mean)
- 1,442.09
- Target (high)
- 1,690.00
Ratings (0m) 31 26 buy · 3 hold · 2 sell
- Strong buy6
- Buy20
- Hold3
- Sell1
- Strong sell1
Recommendation trend
- This month 31
- 1 month ago 31
- 2 months ago 30
- 3 months ago 30
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 11.12 | 10.15 – 12.42 | 7.54 | +47.4% | 24.76B | +28.4% | 13 |
| Next quarter | 10.94 | 10.31 – 11.63 | 8.55 | +27.9% | 23.55B | +18.9% | 6 |
| Current year | 35.35 | 32.68 – 36.22 | 24.21 | +46.0% | 91.86B | +40.9% | 25 |
| Next year | 50.15 | 41.28 – 59.81 | 35.35 | +41.9% | 105.96B | +15.3% | 27 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 30, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Oct 30, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Oct 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 30, 2026 | Argus Research | Maintained | Buy | Buy |
| Oct 21, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 12, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 28, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 22, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Sep 18, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 10, 2026 | HSBC | Maintained | Reduce | Reduce |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 6, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 15, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 14, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jul 13, 2026 | UBS | Maintained | Buy | Buy |
| Jul 13, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 8, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
